FR-alpha (folate receptor alpha, FR-alpha) is a GPI-anchored glycoprotein and serum levels has been found to be elevated in ovarian cancer patients29,30 and correlated to both clinical stage and histological type31,32. Here, FOLR1 is linked to ovarian carcinoma.